{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:25:10Z","timestamp":1761171910335,"version":"build-2065373602"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Albeit fluticasone propionate suspension is effective in treating variant cough in children, there is limited research on the use of Xuanfei Zhisou mixture, and even fewer studies on its combination application. This study aimed to estimate the role of Xuanfei Zhisou mixture (XZM) plus fluticasone propionate suspension (FPS) in the treatment of cough variant in children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      122 children with variant cough from March 2020 to May 2023 were classified into observation therapy (XZM + FPS,\n                      <jats:italic>n<\/jats:italic>\n                      = 60) and control therapy (FPS,\n                      <jats:italic>n<\/jats:italic>\n                      = 60) using block randomization. The clinical effect, inflammatory factor, pulmonary function, peripheral eosinophil count, daytime and nighttime cough scores, immune function and untoward reactions were contrasted in two groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The clinical effect, Forced Vital Capacity (FVC), FEV1 (Forced Expiratory Volume)\/FVC, CD\n                      <jats:sup>3+<\/jats:sup>\n                      , CD\n                      <jats:sup>4+<\/jats:sup>\n                      as well as CD\n                      <jats:sup>4+<\/jats:sup>\n                      \/CD\n                      <jats:sup>8+<\/jats:sup>\n                      of the observation therapy were higher than control therapy. After treatment, interleukin-4 (IL-4), tumor necrosis factor-\u03b1 (TNF-\u03b1), serum amyloid A (SAA), c-reactive protein (CRP), eosinophil count as well as daytime and nighttime cough scores in observation therapy were lower than control therapy. Howbeit, there was no diversity in untoward reactions between the two groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Xuanfei Zhisou mixture plus FPS had conspicuous role in children with variant cough, which assisted in diminishing cough symptoms, raising pulmonary function, reduce inflammatory factor level and upgrading immune function of children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1620973","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:17:38Z","timestamp":1761106658000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of Xuanfei Zhisou mixture plus fluticasone propionate suspension in the treatment of variant cough in children and its effect on serum amyloid A and c-reactive protein"],"prefix":"10.3389","volume":"12","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinling","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningning","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12872-021-01940-8","article-title":"Effect of congenital heart disease on the recurrence of cough variant asthma in children.","volume":"21","author":"Feng","year":"2021","journal-title":"BMC Cardiovasc Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.29271\/jcpsp.2023.09.1040","article-title":"Effect of montelukast combined with budesonide on inflammatory response and pulmonary function in children with cough variant asthma: a meta-analysis.","volume":"33","author":"Wu","year":"2023","journal-title":"J Coll Physicians Surg Pak."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1007\/s00431-023-05115-9","article-title":"Benign acute children myositis: 5 years experience in a tertiary care pediatric hospital.","volume":"182","author":"Attaianese","year":"2023","journal-title":"Eur J Pediatr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S455","DOI":"10.33549\/physiolres.934601","article-title":"Cough reflex sensitivity and fractional exhaled nitric oxide in children with asthma.","volume":"69","author":"Kunc","year":"2020","journal-title":"Physiol Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pcl.2020.09.013","article-title":"Functional respiratory disorders in children.","volume":"68","author":"Hurvitz","year":"2021","journal-title":"Pediatr Clin North Am."},{"key":"B6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12890-023-02721-z","article-title":"An efficacy and safety evaluation of montelukast + fluticasone propionate vs. fluticasone propionate in the treatment of cough variant asthma in children: a meta-analysis.","volume":"23","author":"Wei","year":"2023","journal-title":"BMC Pulm Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.3892\/etm.2019.7894","article-title":"Efficacy of treatment with montelukast, fluticasone propionate and budesonide liquid suspension for the prevention of recurrent asthma paroxysms in children with wheezing disorders.","volume":"18","author":"Ding","year":"2019","journal-title":"Exp Ther Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2165\/00151829-200403030-00005","article-title":"A short-term comparison of fluticasone propionate\/salmeterol with ipratropium bromide\/albuterol for the treatment of COPD.","volume":"3","author":"Donohue","year":"2004","journal-title":"Treat Respir Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1345\/aph.1D547","article-title":"Montelukast-induced generalized urticaria.","volume":"38","author":"Minciullo","year":"2004","journal-title":"Ann Pharmacother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1021\/acs.molpharmaceut.9b00289","article-title":"Pulmonary dissolution of poorly soluble compounds studied in an ex vivo rat lung model.","volume":"16","author":"Eriksson","year":"2019","journal-title":"Mol Pharm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2165\/00148581-200709030-00007","article-title":"Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations.","volume":"9","author":"Gulliver","year":"2007","journal-title":"Paediatr Drugs."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4168308","DOI":"10.1155\/2022\/4168308","article-title":"Assessment of acupoint therapy of traditional chinese medicine on cough variant asthma: a meta-analysis.","volume":"2022","author":"Tu","year":"2022","journal-title":"Biomed Res Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.2169\/internalmedicine.55.5546","article-title":"Clinical efficacy and safety of chinese herbal medicine auxiliary therapy for childhood cough variant asthma: a systematic review and meta-analysis of 20 randomized controlled trials.","volume":"55","author":"Song","year":"2016","journal-title":"Intern Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13063-018-3073-x","article-title":"Chinese herbal medicine for the treatment of cough variant asthma: a study protocol for a double-blind randomized controlled trial.","volume":"20","author":"Fan","year":"2019","journal-title":"Trials."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.13703\/j.0255-2930.2016.12.009","article-title":"[Clinical observation of post-infectious cough differentiated as wind-cold retention in the lung treated with scraping therapy and xuanfei zhisou decoction].","volume":"36","author":"Hu","year":"2016","journal-title":"Zhongguo Zhen Jiu."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2004173","DOI":"10.1183\/13993003.04173-2020","article-title":"European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years.","volume":"58","author":"Gaillard","year":"2021","journal-title":"Eur Respir J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.19288\/j.carolcarrollnki","article-title":"Experimental study on partial pharmacodynamics and acute toxicity of Xuanfeizhike mixture.","author":"Yin","year":"2002","journal-title":"J Yunnan Coll Tradition Chin Med"},{"key":"B18","year":"2024","journal-title":"Guidelines for the Use of Controlled Traditional Chinese Medicines in Children."},{"key":"B19","first-page":"18","article-title":"A systematic review of the efficacy and safety of Xuanfei Zhisou Mixture in treating pediatric bronchitis.","volume":"21","author":"Chang","year":"2023","journal-title":"J China Prescript Drug."},{"key":"B20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1081-120661773-5","article-title":"The use of inhaled corticosteroids for persistent asthma in infants and young children.","volume":"92","author":"Berger","year":"2004","journal-title":"Ann Allergy Asthma Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/15513810600908388","article-title":"Primary thoracic myxoid variant of extrarenal rhabdoid tumor in childhood.","volume":"25","author":"Fowler","year":"2006","journal-title":"Fetal Pediatr Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1097\/MS9.0000000000001326","article-title":"Xiaoqinglong decoction suppresses childhood cough variant asthma and inhibited the body inflammatory response by regulating IL-6\/STAT3 signalling pathway.","volume":"85","author":"Ren","year":"2023","journal-title":"Ann Med Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.29271\/jcpsp.2019.04.345","article-title":"Montelukast and budesonide for childhood cough variant asthma.","volume":"29","author":"Sun","year":"2019","journal-title":"J Coll Physicians Surg Pak."},{"key":"B24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1017\/S0022149X0804827X","article-title":"Toxocariasis associated with chronic cough in childhood: a longitudinal study in Hungary.","volume":"82","author":"Bede","year":"2008","journal-title":"J Helminthol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fphys.2014.00322","article-title":"What is chronic cough in children.","volume":"5","author":"Ioan","year":"2014","journal-title":"Front Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13023-022-02427-1","article-title":"Clinical and genetic spectrum of primary ciliary dyskinesia in Chinese patients: a systematic review.","volume":"17","author":"Peng","year":"2022","journal-title":"Orphanet J Rare Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/ppul.26935","article-title":"Time-dependent gene-environment interactions are essential drivers of asthma initiation and persistence.","volume":"59","author":"Chatziparasidis","year":"2024","journal-title":"Pediatr Pulmonol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e01240","DOI":"10.1002\/rcr2.1240","article-title":"X -linked inheritance of primary ciliary dyskinesia and retinitis pigmentosa due to RPGR variant: A case report and literature review.","volume":"11","author":"Kuroda","year":"2023","journal-title":"Respirol Case Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"113364","DOI":"10.1016\/j.colsurfb.2023.113364","article-title":"A large particle size is required by a nano\/micron sized-fluticasone propionate inhalable suspension for asthma treatment.","volume":"228","author":"Zhang","year":"2023","journal-title":"Colloids Surf B Biointerfaces."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/ppul.26960","article-title":"Clinical efficacy of montelukast sodium combination therapy for cough variant asthma in children: a meta-analysis.","volume":"59","author":"Yang","year":"2024","journal-title":"Pediatr Pulmonol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/jps.21154","article-title":"Combination particles containing salmeterol xinafoate and fluticasone propionate: Formulation and aerodynamic assessment.","volume":"97","author":"Westmeier","year":"2008","journal-title":"J Pharm Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e18335","DOI":"10.1097\/MD.0000000000018335","article-title":"A traditional Chinese patent medicine-Suhuang zhike capsule for cough variant asthma in adults: A protocol of systematic review and meta-analysis of randomized controlled trials.","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine."},{"key":"B33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.pupt.2004.09.004","article-title":"Airway inflammation and remodelling changes in patients with chronic cough: do they tell us about the cause of cough.","volume":"17","author":"Niimi","year":"2004","journal-title":"Pulm Pharmacol Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1378\/chest.06-1025","article-title":"Airway wall thickening in patients with cough variant asthma and nonasthmatic chronic cough.","volume":"131","author":"Matsumoto","year":"2007","journal-title":"Chest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12931-022-02104-8","article-title":"Characteristics of different asthma phenotypes associated with cough: a prospective, multicenter survey in China.","volume":"23","author":"Zhou","year":"2022","journal-title":"Respir Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2147\/JAA.S452097","article-title":"Bibliometric analysis of cough variant asthma from 1993 to 2022.","volume":"17","author":"Zhu","year":"2024","journal-title":"J Asthma Allergy."},{"key":"B37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neuroscience.2020.03.008","article-title":"IL-4 switches microglia\/macrophage M1\/M2 polarization and alleviates neurological damage by modulating the JAK1\/STAT6 pathway following ICH.","volume":"437","author":"He","year":"2020","journal-title":"Neuroscience."},{"key":"B38","doi-asserted-by":"publisher","first-page":"102847","DOI":"10.1016\/j.redox.2023.102847","article-title":"The mitochondria-targeted sulfide delivery molecule attenuates drugs-induced gastropathy. Involvement of heme oxygenase pathway.","volume":"66","author":"Magierowska","year":"2023","journal-title":"Redox Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cca.2006.07.012","article-title":"Establishment of an in-house ELISA and the reference range for serum amyloid A (SAA): complementarity between SAA and C-reactive protein as markers of inflammation.","volume":"376","author":"Wu","year":"2007","journal-title":"Clin Chim Acta"},{"key":"B40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-2362.1996.159291.x","article-title":"Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice.","volume":"26","author":"Malle","year":"1996","journal-title":"Eur J Clin Invest."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2174\/0929867323666160418114600","article-title":"Structure and expression of different serum amyloid A (SAA) variants and their concentration-dependent functions during host insults.","volume":"23","author":"De Buck","year":"2016","journal-title":"Curr Med Chem."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1620973\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:17:40Z","timestamp":1761106660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1620973\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":41,"alternative-id":["10.3389\/fmed.2025.1620973"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1620973","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"article-number":"1620973"}}